Skip to main content
. 2020 Feb 10;10(7):3022–3034. doi: 10.7150/thno.42507

Figure 5.

Figure 5

Autoantibody measurement in plasma samples by the multiplexed electrochemical immunosensing platform. (A) Schematic design of the proposed strategy. (B, C) Amperometric responses obtained for the TAAs were larger for the premalignant and CRC subjects in comparison to the asymptomatic, where they were almost undetectable. (D) Percentage of patients positive to CRC related autoantibodies detected by the biosensor. (E) ROC curve of autoantibody detection against all targets using the electrochemical immunosensing platform. Premalignant, premalignant colorectal individuals.